First European Patient Congress Depression for those affected by depression and their close relations takes place online on December 7, 2024

28.11.2024 10:35:59 CET | news aktuell GmbH | Press release

Share

Free online-event offers information and experience-sharing.

Frankfurt am Main, 28.11.2024: The European Patient Congress Depression, hosted by the European Alliance Against Depression (EAAD), will take place on December 7, 2024. This free online-event is designed to support individuals affected by depression and their relatives, providing a platform for expert guidance, patient perspectives, and practical advice on managing mental health challenges.

“The congress aims to support patients in becoming experts on their own condition,” says Professor Ulrich Hegerl, president of EAAD and host of the event. “It intends to foster a supportive community and to show them that they are not alone. For the first time, attendees from all over Europe will have the opportunity to learn from professionals and from one another.”

Agenda Highlights:

  • Patient and partner experience reports
  • Keynotes on psychotherapy, pharmacotherapy, and repetitive transcranial magnetic stimulation (rTMS)
  • Tried and tested self-help-tips
  • Panel addressing how to communicate about mental health  

Open to anyone affected by or supporting someone with depression, the event will take place on Saturday, December 7, 2024, from 10:00 to 15:30 CET. Registration is free, and participation is via Zoom. The event will be in English.

For more information and registration, visit www.epc-depression.com.

Each year, 40 million people in Europe experience depression. According to the WHO, depression is the leading cause of ill health and disability worldwide.

 

About EAAD

The European Alliance Against Depression (EAAD), an international non-profit organisation based in Frankfurt am Main and Leipzig, Germany, seeks to improve care and optimise treatment for patients with depressive disorders and to prevent suicidal behaviour.

Established in 2004, EAAD currently has 32 members in Europe, Australia, Canada, Africa, and Chile. www.eaad.net

 

Contact:
Pia Hauck
+491759824706
contact@eaad.net

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Ship parades, evening shows and partner region Liverpool The 837th HAMBURG PORT ANNIVERSARY with a top programme11.3.2026 14:02:16 CET | Press release

(Hamburg, 11 March 2026) From 8 to 10 May 2026, Hamburg is celebrating its 837th HAMBURG PORT ANNIVERSARY. The programme includes traditional highlights such as the arrival and departure parades and the unique tugboat ballet, as well as several evening shows and the fascinating fireworks display. The programme will be supplemented by new events on the water and on land. The Big Arrival Parade on Friday, 8 May, at 1:30 p.m. marks the start of the festivities and is always an unforgettable experience: more than 100 impressive ships sail up the Elbe right before the eyes of the spectators. The majestic tall ship, the Norwegian three-masted barque Statsraad Lehmkuhl, is particularly stunning. The floating Elbe stage in front of the Landungsbrücken is THE artistic anchor of the HAMBURG PORT ANNIVERSARY: Elbe in Concert presents visitors with rousing live music and impressive performances, creating a unique atmosphere against the backdrop of the harbour skyline at night. This year’s partner

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye